Name | Type | Posted | Actions |
|---|---|---|---|
A19 Solicitation - 75D30125R00065.pdf | Jan 17, 2025 | ||
Subcontracting Plan Submission Link | LINK | Jan 17, 2025 | |
A19 Vaccine Order Limitation Chart.docx | DOCX | Jan 16, 2025 | |
A19 Authorized Distributor of Record (ADR) Agreement.docx | DOCX | Jan 16, 2025 | |
A19 Solicitation - 75D30125R00065.pdf | Jan 16, 2025 |
FY25 Vaccines for Children
Contact and place of performance
James Sprigler
Atlanta, GA 30341
USA
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA 93), guarantees f...
View moreThe Centers for Disease Control and Prevention (CDC) Office of Acquisition Services has issued this combined synopsis and solicitation to award contracts for the purchase of standard commercial pediatric vaccines. Established under the Vaccines for Children (VFC) program, this initiative guarantees federal support to provide sufficient vaccine quantities to states for specific populations, including Medicaid-eligible, uninsured, and American Indian or Alaska Native children, as well as underinsured children at qualifying health centers. These contracts allow the government to utilize VFC and Section 317 funds to procure vaccines at prices below commercial market rates, and awardees may allow states to purchase additional quantities using local funds for children not federally eligible.
Solicitation 75D30125R00065 is identified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals. Eligible offerors must be manufacturers of pediatric vaccines as defined by 42 U.S.C. 1396s, which includes entities that manufacture, import, process, or distribute vaccines under their own labels. The primary place of performance is Atlanta, Georgia, and the agency representative for this requirement is James Sprigler.
The response deadline for this solicitation is January 30, 2025. This notice includes five attachments: the primary solicitation document, a subcontracting plan submission link, a vaccine order limitation chart, and an authorized distributor of record agreement. These materials support the program's objective of implementing effective immunization practices and achieving high coverage rates for children 18 years of age or younger.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.